Treatment strategies for neuromyelitis optica - Wikidata - awgldk - TriplyDB

Treatment strategies for neuromyelitis optica

Treatment strategies for neuromyelitis optica

http://www.wikidata.org/entity/Q57298520

about

Treatment strategies for neuromyelitis optica

http://www.wikidata.org/entity/Q57298520

description

wetenschappelijk artikel

@nl

name

Treatment strategies for neuromyelitis optica

@en

Treatment strategies for neuromyelitis optica

@nl

type

label

Treatment strategies for neuromyelitis optica

@en

Treatment strategies for neuromyelitis optica

@nl

prefLabel

Treatment strategies for neuromyelitis optica

@en

Treatment strategies for neuromyelitis optica

@nl

P1476

Q57298520-DCA5BCFB-7918-481F-9117-D630E403A7CE

P2093

Q57298520-26287296-4710-4292-A884-91183D5B8199

Q57298520-650C1C0B-2D78-492B-BCB9-B6EF0ABA3795

Q57298520-A41ABEA0-2EE2-4691-986A-83F32DC71459

Q57298520-A62C67A3-01EA-43EE-80C9-30DC82FD4230

P2860

Q57298520-0ACD5AD8-E5FC-40AD-8930-0500A12DCBEC

Q57298520-0F407D26-CFF4-4DC5-B01B-2AC19844BFE2

Q57298520-164BED21-1ECC-4319-A91E-DA0C0BC74C74

Q57298520-1B5516F8-5BA1-4B2B-BF30-A6B841CB6F2C

Q57298520-1E0FA536-6C7D-42A9-9FED-95D9BCB63DCF

Q57298520-26E73EEB-4854-4B8E-B2FC-6BD85A1287D9

Q57298520-28D10C88-0C2B-44A9-B5DE-697EAA8F6498

Q57298520-29CD3A37-81DA-458F-B14F-7A34B2CDB2D0

Q57298520-2A08F32A-D792-49BF-BC8C-199E29CCC0B2

Q57298520-2E4BECDA-3FBF-40BF-B1F3-8EABC6A56F55

P304

Q57298520-E12B3C1A-0274-4F06-A0EB-11625F081544

P31

Q57298520-E5E1DD26-77E8-4147-A6E2-D0951A9FB7E6

P356

Q57298520-F51AB880-883F-4A68-AB0C-E3BBB5B1712A

P407

Q57298520-A13F7BAA-6A29-4278-BC9D-B720D89CC997

P433

Q57298520-207162CB-544D-4CB3-AB41-9E1AC72A970A

P478

Q57298520-6E03BEB1-8724-4363-96BE-C1190CA9D8A0

P698

Q57298520-23270877-59BA-4F8C-8DD8-FA9D8AE52365

P932

Q57298520-5F8D4D97-39B4-42AA-9803-8236CA28F88C

P356

TCMJ.TCMJ_102_18

P1476

Treatment strategies for neuromyelitis optica

@en

P2093

Jia-Kang Wang

http://www.w3.org/2001/XMLSchema#string

Kung-Hung Lin

http://www.w3.org/2001/XMLSchema#string

Rong-Kung Tsai

http://www.w3.org/2001/XMLSchema#string

Tzu-Lun Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Aquaporin 4 and neuromyelitis optica

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica

Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

Optic neuritis in neuromyelitis optica.

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.

The spectrum of neuromyelitis optica.

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients.

P304

204-208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/TCMJ.TCMJ_102_18

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P698

30305782

http://www.w3.org/2001/XMLSchema#string

P932

6172906

http://www.w3.org/2001/XMLSchema#string